These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14720068)

  • 1. Spotlight on zanamivir in influenza.
    Cheer SM; Wagstaff AJ
    Am J Respir Med; 2002; 1(2):147-52. PubMed ID: 14720068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zanamivir: an update of its use in influenza.
    Cheer SM; Wagstaff AJ
    Drugs; 2002; 62(1):71-106. PubMed ID: 11790157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zanamivir: a review of its use in influenza.
    Dunn CJ; Goa KL
    Drugs; 1999 Oct; 58(4):761-84. PubMed ID: 10551442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
    Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A
    J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of zanamivir on duration and resolution of influenza symptoms.
    Monto AS; Moult AB; Sharp SJ
    Clin Ther; 2000 Nov; 22(11):1294-305. PubMed ID: 11117654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
    Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
    N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zanamivir: a review of clinical safety in individuals at high risk of developing influenza-related complications.
    Gravenstein S; Johnston SL; Loeschel E; Webster A
    Drug Saf; 2001; 24(15):1113-25. PubMed ID: 11772145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of inhaled zanamivir in the treatment and prevention of influenza].
    Abad-Santos F; Gallego Sandín S; Novalbos Reina J; Martínez Sancho E; Gálvez Múgica MA
    An Med Interna; 2001 Feb; 18(2):93-9. PubMed ID: 11322008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.
    Lancet; 1998 Dec; 352(9144):1877-81. PubMed ID: 9863784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial.
    Hedrick JA; Barzilai A; Behre U; Henderson FW; Hammond J; Reilly L; Keene O
    Pediatr Infect Dis J; 2000 May; 19(5):410-7. PubMed ID: 10819336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials.
    Lalezari J; Campion K; Keene O; Silagy C
    Arch Intern Med; 2001 Jan; 161(2):212-7. PubMed ID: 11176734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults.
    Kaiser L; Keene ON; Hammond JM; Elliott M; Hayden FG
    Arch Intern Med; 2000 Nov; 160(21):3234-40. PubMed ID: 11088083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
    Höffken G; Gillissen A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):169-73. PubMed ID: 12458354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
    Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
    Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ;
    N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis.
    Monto AS; Webster A; Keene O
    J Antimicrob Chemother; 1999 Nov; 44 Suppl B():23-9. PubMed ID: 10877459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study.
    Kaiser L; Henry D; Flack NP; Keene O; Hayden FG
    Clin Infect Dis; 2000 Mar; 30(3):587-9. PubMed ID: 10722450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zanamivir: a review of clinical safety.
    Freund B; Gravenstein S; Elliott M; Miller I
    Drug Saf; 1999 Oct; 21(4):267-81. PubMed ID: 10514019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.